Last reviewed · How we verify

NCT07402421: MRI in ELs

DWI MRI for Differentiating Endometrial Lesions in Comparison With Histopathology

Not yet recruiting Last updated 11 February 2026
What this trial tests

trial testing Diagnostic imaging (DWI MRI) in comparison with histopathology in Endometrial Lesions in 30 participants. Not yet recruiting.

Timeline
5 February 2026
Primary endpoint
5 May 2026
5 June 2026

Quick facts

Lead sponsorSohag University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment30
Start date5 February 2026
Primary completion5 May 2026
Estimated completion5 June 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Eligibility, female only, with Endometrial Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the diagnostic accuracy of Diffusion Weighted Magnetic Resonance Imaging (DW MRI) in differentiating benign from malignant endometrial lesions, using histopathological examination as the reference standard.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07402421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing